default author photo

Lorenzo Belluomini

University of Verona

Via dell'Artigliere, 8

Verona, 37129

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

134

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Advanced-Stage Alk-Positive Non–Small-Cell Lung Cancer (Nsclc) Patients: Real-World Treatment Patterns and Outcomes from the Italian Biomarker Atlas Database

Number of pages: 24 Posted: 15 May 2025
“Vito Fazzi” Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, Università degli Studi di Udine - Azienda Sanitaria Universitaria Integrata di Udine, affiliation not provided to SSRN, Ospedale Giovanni Paolo II, affiliation not provided to SSRN, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Pederzoli Hospital-Peschiera del Garda, University of Pavia, University Hospital of Parma, University of Milano-Bicocca - Fondazione IRCCS San Gerardo dei Tintori, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Florence, University of Pisa, University Hospital Careggi, affiliation not provided to SSRN, Cardinal Massaia Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, ASST Papa Giovanni XXIII, Università degli Studi di Genova, Regione Veneto - Azienda Ulss 3 Serenissima, affiliation not provided to SSRN, Ospedale Michele e Pietro Ferrero - Verduno, affiliation not provided to SSRN, affiliation not provided to SSRN, Azienda Ospedaliera Ospedali Riuniti Marche Nord, affiliation not provided to SSRN, affiliation not provided to SSRN, San Giovanni di Dio Hospital,, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Naples Federico II, University of Turin, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 65 (916,100)

Abstract:

Loading...

alectinib, ALK, Non-small-cell lung cancer, ALK TKIs, Lorlatinib

2.

Low Ft3/Ft4 Ratio as a Proxy for Muscle Wasting in Patients with Advanced Non-Small Cell Lung Cancer Treated with Upfront Pembrolizumab

Number of pages: 12 Posted: 31 Mar 2025
University of Verona, University of Verona, University of Verona, University of Verona, University of Verona, University of Verona, University of Verona, University of Verona, University of Verona, University of Parma, affiliation not provided to SSRN, affiliation not provided to SSRN, IRCCS Regina Elena National Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Parma, affiliation not provided to SSRN, University of Verona, University of Verona - Hospital Trust and University of Verona
Downloads 39 (1,196,171)

Abstract:

Loading...

Non-Small Cell Lung Cancer (NSCLC), Muscle Wasting, Immune Checkpoint Inhibitors (ICIs), Thyroid Hormones, Sarcopenia, Body Composition.

3.

Prognostic Impact of Interleukin-8 Levels in Lung Cancer: A Meta-Analysis and a Bioinformatic Validation

Number of pages: 26 Posted: 06 Jun 2024
University of Verona, University of Verona, University of Campania Luigi Vanvitelli, University of Verona, University of Verona, University of Verona, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Verona, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Verona, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Gynecologic Unit, University of Verona - Hospital Trust and University of Verona
Downloads 30 (1,318,317)

Abstract:

Loading...

lung cancer, Interleukin-8, Biomarkers, prognosis